# Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer

> **NCT01012141** · PHASE2 · COMPLETED · sponsor: **Centre Jean Perrin** · enrollment: 30 (actual)

## Conditions studied

- Metastatic Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** phytochemical
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT01012141
- **Lead sponsor:** Centre Jean Perrin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01012141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01012141, "Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01012141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*